Clofarabine in Pediatric Acute Relapsed or Refractory Leukemia: Where Do We Stand on the Bridge to Hematopoietic Stem Cell Transplantation?

BACKGROUND: Despite pronounced improvement in overall survival (OS) in pediatric leukemia, a proportion of patients continue to suffer from lack of response or relapse, and the management of such patients is exceedingly difficult. Immunotherapy and engineered chimeric antigen receptor (CAR) T-cell t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramiz, Sarah, Elhaj, Osama, Siddiqui, Khawar, Khan, Saadiya, AlSaedi, Hawazen, AlAnazi, Awatif, Al-Ahmari, Ali, Al-Jefri, Abdullah, Sahvan, Oudai, Ayas, Mouhab, Ghemlas, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990710/
https://www.ncbi.nlm.nih.gov/pubmed/36895294
http://dx.doi.org/10.14740/jh1065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990710/
https://www.ncbi.nlm.nih.gov/pubmed/36895294
http://dx.doi.org/10.14740/jh1065

Ejemplares similares